PoliCheck Network
← Back to bills
H.R. 10073119th CongressReferred to the House Committee on Natural Resources.

Critically Endangered Animals Conservation Act of 2026

Introduced: Aug 10, 2026
Latest action: Aug 10, 2026

Latest Action

Referred to the House Committee on Natural Resources.

1
Primary Sponsors
2
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Summary Ready

What this bill does

The Critically Endangered Animals Conservation Act of 2026 creates a dedicated grant program and fund within the Department of the Interior to support conservation efforts for critically endangered animal species outside the United States.

Who it affects

* **Eligible grant recipients:** Foreign wildlife management authorities (if the species' habitat falls within their jurisdiction) and individuals, groups, or organizations that demonstrate conservation expertise and capacity. * **Federal agencies:** The Department of the Interior, specifically the Secretary of the Interior, who must run the grant program in consultation with other federal officials.

What would change

* **New Grant Program:** The Secretary of the Interior is required to establish and run a competitive grant program funded by a new dedicated account. * **Eligible Species:** Conservation grants can cover animal species listed as *Endangered* or *Critically Endangered* on the International Union for Conservation of Nature (IUCN) Red List. They can also cover species categorized as *Data Deficient* or a lower threat level if the Secretary determines the species faces new threats or a declining population. This applies to live animals, eggs, offspring, carcasses, and animal parts or products. * **Application Requirements:** Applicants must submit grant proposals that include proof of host or local government support if required by the Secretary.

Money or funding

The bill creates a dedicated account within the Department of the Interior to fund the competitive grant program. The summary does not specify exact dollar amounts or sources of revenue for this fund.

Important exceptions or limits

* **Geographic Limitation:** The bill only applies to species whose natural range falls entirely or partly outside the United States. * **Funding Restrictions:** Any entity already receiving funds for a specific species from a Multinational Species Conservation Fund in which the U.S. Fish and Wildlife Service participates is prohibited from receiving grant money under this bill for that same species.

Plain-English bottom line

This bill requires the U.S. Department of the Interior to create a new dedicated fund and competitive grant program to support international conservation efforts for threatened or declining animal species, excluding groups already receiving money for those species through existing U.S. multinational wildlife funds.

This summary was generated by AI from the official bill text. It is intended to make legislation easier to understand and does not replace the original legal language.

AI model: gemini-3.6-flashUpdated: Sep 20, 2026Review official bill text ↗

Official Summary

Official legislative summary associated with this bill.

No official summary is currently available.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

Recorded Actions

Official legislative actions recorded for this measure.

H11100Aug 10, 2026

Referred to the House Committee on Natural Resources.

Official source ↗
Intro-HAug 10, 2026

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 10073. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

COLLEGE OF AMERICAN PATHOLOGISTS

Registrant: COLLEGE OF AMERICAN PATHOLOGISTS

3rd Quarter (July 1 - Sep 30)
Oct 17, 2025

Reported lobbying issue

Health Issues: H.R. 1, the One Big, Beautiful Bill Act H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025 Improving seniors' timely access to care act (S. 1816 / H.R. 3514) Genomic Data Protection Act Tariffs S. 998, Medical Supply Chain Resiliency Act S 106 / HR 539 - Chiropractic Medicare Coverage Modernization Act PAMA reform HR 2483, Support for Patients and Communities Reauth Act HR 2484, Seniors access to Critical medications act Reducing Hereditary Cancer Act S 1399, the Health Tech Investment Act H.R. 3580, the Oversight of Medicare Billing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention act LCD legislation S 1866 - National Breast and Cervical Cancer Early Detection Program S 1882 - to expand research and training on reproductive health conditions HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act CDC Division of Cancer Prevention and Control and cancer registries appropriations S. 2439 and H.R. 4731, Resident Physician Shortage Reduction Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 HR 3164 - Ensuring Community Access to Pharmacy Services Act (ECAPS) S 2800 - Pharmacy and Medically Underserved Areas Enhancement Act S 2420 / H.R. 4710 - No Surprises Act Enforcement Act S 2793 - Ensuring Access to Essential Providers Act of 2025 H.R. 5582 / S 2355 - Patients Deserve Price Tags Act Issues related to tariffs Issues related to public health Medicare/Medicaid: FY 2026 Appropriations Student VISA issues Price Tags / Transparency Legislation CDC funding NIH Funding CLIAC reinstatement Issues relating to surprise medical bills Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Advocating for relief from cuts to evaluation and management codes within Medicare Issues relating to the debt limit Issues relating to site-neutral payments Issue relating to artificial intelligence Issues relating to combatting fentanyl crisis Issues relating to Medicare coverage pathways Researching Long Covid Fees paid on electronically submitting to insurers Issues relating to the Clinical Laboratory Fee Schedule Issues relating to forensic pathologist loan repayment Funding for the CDC AMD program Funding for lab test harmonization Issues surrounding Health Data Privacy Issues surrounding the Change Healthcare Cyber Attack Medicare payment reform S.4338 - Pay PCPs Act of 2024 Challenges facing independent medicine PTAC Reform Issues relating to blood donations Issues relating to the local coverage determination process Issues relating to GME Issues relating to laboratory accreditation procedures of IVF centers Issues relating to site neutral payment reform Issues relating to Medicaid funding S. 2761 and H.R. 5269, the RESULTS Act Issues related to cancer Issues related to the Medicare Access and CHIP Reauthorization Act of 2015

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $124,816

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

COLLEGE OF AMERICAN PATHOLOGISTS

Registrant: COLLEGE OF AMERICAN PATHOLOGISTS

2nd Quarter (Apr 1 - June 30)
Jul 18, 2025

Reported lobbying issue

Health Issues: H.R. 1, the One Big, Beautiful Bill Act H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025 Seniors timely access to care act (S. 1816 / H.R. 3514) Genomic Data Protection Act Tariffs S. 998, Medical Supply Chain Resiliency Act S 106 / HR 539 - Chiropractic Medicare Coverage Modernization Act PAMA reform HR 2483, Support for Patients and Communities Reauth Act HR 2484, Seniors access to Critical medications act Reducing Hereditary Cancer Act S 1399, the Health Tech Investment Act H.R. 3580, the Oversight of Medicare Billing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention act LCD legislation S 1866 - National Breast and Cervical Cancer Early Detection Program S 1882 - to expand research and training on reproductive health conditions HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act Medicare/Medicaid: FY 2026 Appropriations Student VISA issues Price Tags / Transparency Legislation CDC funding NIH Funding CLIAC reinstatement Issues relating to surprise medical bills Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Advocating for relief from cuts to evaluation and management codes within Medicare Issues relating to the debt limit Issues relating to site-neutral payments Issue relating to artificial intelligence Issues relating to combatting fentanyl crisis Issues relating to Medicare coverage pathways Researching Long Covid Fees paid on electronically submitting to insurers Issues relating to the Clinical Laboratory Fee Schedule Issues relating to forensic pathologist loan repayment Funding for the CDC AMD program Funding for lab test harmonization Issues surrounding Health Data Privacy Issues surrounding the Change Healthcare Cyber Attack Medicare payment reform S.4338 - Pay PCPs Act of 2024 Challenges facing independent medicine PTAC Reform Issues relating to blood donations Issues relating to the local coverage determination process Issues relating to GME Issues relating to laboratory accreditation procedures of IVF centers Issues relating to site neutral payment reform Issues relating to Medicaid funding

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $149,447

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Registrant: AMERICAN SOCIETY OF ANESTHESIOLOGISTS

2nd Quarter (Apr 1 - June 30)
Jul 17, 2025

Reported lobbying issue

Medicare/Medicaid: Medicare sequester, PAYGO H.R. 10073, Medicare Patient Access and Practice Stabilization Act of 2024: payment rates H.R.8812, I CAN Act: provision of service under Medicare H.R. 2474, Strengthening Medicare for Patients and Providers Act: an annual inflation adjustment to Medicare physician payments Medicare Advantage Upcoding Medicare for All/Public Option Rural Anesthesiology: Rural Pass Through Out of Network/Out of Network Payment Network Adequacy Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Perioperative Surgical Home Model Bundled payments CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services Medicare Physician Fee Schedule Rule CMS Value-Based purchasing Conditions of Participation - Anesthesia services, opt-outs, supervision Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation Graduate Medical Education Value-based modifier - PPACA QCDR - Qualified Clinical Data Registry Evaluation and Monitoring codes & cuts Certified Anesthesiologist Assistants CMS: Federal Independent Dispute Resolution (IDR) Process, Batching Budget neutrality Medicare Economic Index: Medicare inflationary increase Medicaid Health Issues: Practice Support/Grants to Practice H.R. 10331, Anesthesia for All Act: prohibit time caps on reimbursement for anesthesia services H.R.1173, Patients Right to Know Their Medication Act of 2023: prescription drug labeling H.R. 9572, No Surprises Enforcement Act: strengthen compliance with the No Surprises Act H.R. 3595, Safe Prescribing Through Reporting Act of 2025: disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act: Ambulatory Surgical Centers H.R.6205, Healthcare Workforce Resilience Act: physician workforce H.R.7591, National Patient Safety Board Act of 2024: patient safety S.1302, Resident Physician Shortage Reduction Act of 2023: residency positions S.665, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status Medical liability S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas Public Law No. 113-5, Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA): preparedness for public health Lorna Breen Reauthorization H.R.27, HALT Fentanyl Act: fentanyl scheduling and registration requirements H.R. 1227, Alternatives to PAIN Act of 2025: access to non-opioid pain management options S. 475, Alternatives to PAIN Act of 2025: access to non-opioid pain management options H.R. 3259, NOPAIN Act: Opioids S. 586, NOPAIN Act: Opioids S. 1292, Non-Opioid Directive Act: Opioids H.R. 7961, SAVE Act: To protect hospital personnel from violence, and for other purposes. H.R.833, Save America's Rural Hospitals: rural pass through H.R. 7725, Embracing anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act: medical school funding H.R. 2671, Specialty Physicians Advancing Rural Care Act (the SPARC Act): student loan repayment programs to support specialty medical care in rural areas Pre-authorization; prior authorization Affordable Care Act reform efforts 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care Resident Education Deferred Interest Act (REDI Act): Student loan relief Student Loan Forgiveness for Frontline Health Workers Act: Student loan relief 21st Century Cures Initiative H.R. 4369, National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act: Drug shortages DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone access FDA Opioids Ketamine use by law enforcement Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee USP - US Pharmacopeia National Pain Strategy Provider Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health Certified Anesthesiologist Assistants Blood management Long COVID research Anesthesia workforce shortages CDC Opioid Prescribing Guideline 2024 Labor/HHS/Education appropriations bill Defense Health Agency anesthesia policy Maternal Mortality/Maternal Care Deserts Change Healthcare, Change Healthcare data breach Insurance reform, shared savings, insurer accountability NIH: Funding, Indirect Costs, Indirect Grants, Overhead Veterans: Veterans Affairs Advance Practice Registered Nurses Mil Con VA: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act VA Physician/Provider Hiring VA Stone Memorandum, April 21, 2020: physician supervision Federal Supremacy Initiative (National Standards of Practice): reduction in patient safety standard H.R. 3347/S. 2070, Protect Lifesaving Anesthesia Care for Veterans Act of 2023: anesthesia care H.R. 543, Elizabeth Dole Home Care Act of 2023: services for veterans Defense Health Agency (DHA): Physician-led care and scope of practice National Defense Authorization Act: VA physicians/providers Safe Anesthesia Standards in the VA

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Government Accountability Office (GAO) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Agency for Healthcare Research & Quality (AHRQ) Centers For Disease Control & Prevention (CDC) Defense, Dept of (DOD) Drug Enforcement Administration (DEA) Federal Trade Commission (FTC) Food & Drug Administration (FDA) Justice, Dept of (DOJ) Natl Institutes of Health (NIH) Occupational Safety & Health Administration (OSHA) Office of Management & Budget (OMB) Veterans Affairs, Dept of (VA) White House Office

Reported filing-period amount: $270,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Registrant: AMERICAN SOCIETY OF ANESTHESIOLOGISTS

1st Quarter (Jan 1 - Mar 31)
Apr 17, 2025

Reported lobbying issue

Medicare/Medicaid: Medicare sequester, PAYGO H.R. 10073, Medicare Patient Access and Practice Stabilization Act of 2024: payment rates H.R.8812, I CAN Act: provision of service under Medicare H.R. 2474, Strengthening Medicare for Patients and Providers Act: an annual inflation adjustment to Medicare physician payments Medicare Advantage Upcoding Medicare for All/Public Option Rural Anesthesiology: Rural Pass Through Out of Network/Out of Network Payment Network Adequacy Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Perioperative Surgical Home Model Bundled payments CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services Medicare Physician Fee Schedule Rule CMS Value-Based purchasing Conditions of Participation - Anesthesia services, opt-outs, supervision Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation Graduate Medical Education Value-based modifier - PPACA QCDR - Qualified Clinical Data Registry Evaluation and Monitoring codes & cuts Certified Anesthesiologist Assistants CMS: Federal Independent Dispute Resolution (IDR) Process, Batching Budget neutrality Medicare Economic Index: Medicare inflationary increase Health Issues: Practice Support/Grants to Practice H.R. 10331, Anesthesia for All Act: prohibit time caps on reimbursement for anesthesia services H.R.1173, Patients Right to Know Their Medication Act of 2023: prescription drug labeling H.R. 9572, No Surprises Enforcement Act: strengthen compliance with the No Surprises Act S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act: Ambulatory Surgical Centers H.R.6205, Healthcare Workforce Resilience Act: physician workforce H.R.7591, National Patient Safety Board Act of 2024: patient safety S.1302, Resident Physician Shortage Reduction Act of 2023: residency positions S.665, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status Medical liability S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas Public Law No. 113-5, Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA): preparedness for public health Lorna Breen Reauthorization H.R.27, HALT Fentanyl Act: fentanyl scheduling and registration requirements H.R. 1227, Alternatives to PAIN Act of 2025: access to non-opioid pain management options S. 475, Alternatives to PAIN Act of 2025: access to non-opioid pain management options H.R. 3259, NOPAIN Act: Opioids S. 586, NOPAIN Act: Opioids S. 1292, Non-Opioid Directive Act: Opioids H.R. 7961, SAVE Act: To protect hospital personnel from violence, and for other purposes. H.R.833, Save America's Rural Hospitals: rural pass through H.R. 7725, Embracing anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act: medical school funding H.R. 2671, Specialty Physicians Advancing Rural Care Act (the SPARC Act): student loan repayment programs to support specialty medical care in rural areas Pre-authorization; prior authorization Affordable Care Act reform efforts 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care Resident Education Deferred Interest Act (REDI Act): Student loan relief Student Loan Forgiveness for Frontline Health Workers Act: Student loan relief 21st Century Cures Initiative H.R. 4369, National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act: Drug shortages DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Ketamine use by law enforcement Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee USP - US Pharmacopeia National Pain Strategy Provider Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health Certified Anesthesiologist Assistants Blood management Long COVID research Anesthesia workforce shortages CDC Opioid Prescribing Guideline 2024 Labor/HHS/Education appropriations bill Defense Health Agency anesthesia policy Maternal Mortality/Maternal Care Deserts Change Healthcare, Change Healthcare data breach Insurance reform, shared savings, insurer accountability NIH: Funding, Indirect Costs, Indirect Grants, Overhead Veterans: Veterans Affairs Advance Practice Registered Nurses Mil Con VA: Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill VA Physician/Provider Hiring VA Stone Memorandum, April 21, 2020: physician supervision Federal Supremacy Initiative (National Standards of Practice): reduction in patient safety standard H.R. 3347/S. 2070, Protect Lifesaving Anesthesia Care for Veterans Act of 2023: anesthesia care H.R. 543, Elizabeth Dole Home Care Act of 2023: services for veterans Defense Health Agency (DHA): Physician-led care and scope of practice National Defense Authorization Act: VA physicians/providers

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Government Accountability Office (GAO) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Agency for Healthcare Research & Quality (AHRQ) Centers For Disease Control & Prevention (CDC) Defense, Dept of (DOD) Drug Enforcement Administration (DEA) Federal Trade Commission (FTC) Food & Drug Administration (FDA) Justice, Dept of (DOJ) Natl Institutes of Health (NIH) Occupational Safety & Health Administration (OSHA) Office of Management & Budget (OMB) Veterans Affairs, Dept of (VA) White House Office

Reported filing-period amount: $250,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

COLLEGE OF AMERICAN PATHOLOGISTS

Registrant: COLLEGE OF AMERICAN PATHOLOGISTS

1st Quarter (Jan 1 - Mar 31)
Apr 16, 2025

Reported lobbying issue

Health Issues: HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act Medicare/Medicaid: Issues relating to surprise medical bills Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Advocating for relief from cuts to evaluation and management codes within Medicare Issues relating to the debt limit Issues relating to site-neutral payments Issue relating to artificial intelligence Issues relating to combatting fentanyl crisis Issues relating to Medicare coverage pathways Researching Long Covid Fees paid on electronically submitting to insurers Issues relating to the Clinical Laboratory Fee Schedule Issues relating to forensic pathologist loan repayment Funding for the CDC AMD program Funding for lab test harmonization Issues surrounding Health Data Privacy Issues surrounding the Change Healthcare Cyber Attack Medicare payment reform S.4338 - Pay PCPs Act of 2024 Challenges facing independent medicine PTAC Reform Issues relating to blood donations Issues relating to the local coverage determination process Issues relating to GME Issues relating to laboratory accreditation procedures of IVF centers Issues relating to site neutral payment reform Issues relating to Medicaid funding

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $217,588

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗
Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.